Stay informed with the latest updates for the inheritable blood disorders community. Industry BioMarin Provides Update Including Next Steps for Investigational Gene… Jan 11, 2022 Industry Sigilon Announces a Priority Shift in Light of Clinical Trial Setbacks Dec 17, 2021 Industry uniQure and CSL Behring Announce Trial Updates for Hemophilia B Gene… Dec 9, 2021 Industry Sigilon Reports Trial Updates for Investigational Hemophilia A Therapy Nov 29, 2021 Industry Spark Announces Multiyear Data Update for Investigational Gene Therapy Nov 19, 2021 NHF & Community NHF Applauds Implementation of the Hemophilia SNF Access Act Oct 1, 2021 Medical Prophylaxis Indication Restored for BeneFIX® Sep 14, 2021 Industry Spark Provides Trial Updates for Investigational Gene Therapy SPK-8011 Aug 2, 2021 Industry FDA Places Clinical Hold on Sigilon’s Investigational Hemophilia Therapy Jul 12, 2021 Industry BioMarin Presents Positive Safety and Efficacy Data for their… May 27, 2021 Industry Gene Therapy Trial Data Suggests Efficacy in the Presence of Antibodies May 25, 2021 Industry Gene Therapy Licensing Agreement Between uniQure and CSL Now in Effect May 7, 2021 Industry uniQure Announces End of Clinical Hold on Hemophilia B Gene Therapy… Apr 27, 2021 Industry uniQure Announces Findings from HCC Case Investigation Mar 30, 2021 Industry Update to Hemlibra® (emicizumab-kxwh) USPI Mar 12, 2021 Pagination First page Previous page Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Last page
